FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2033976809> ?p ?o ?g. }

• W2033976809 endingPage "83" @default.
• W2033976809 startingPage "78" @default.
• W2033976809 abstract "Riluzole is the only therapy proven in clinical trials to prolong survival in patients with motor neurone disease (MND). Prior to its listing by the Australian Pharmaceutical Benefits Advisory Scheme in June 2003, the aim of the present study was to provide Australian patients with MND early access to riluzole and to expand the safety profile data of this therapy. Patients with MND were referred to the programme by neurologists covering the Sydney metropolitan region. To be eligible to receive riluzole, patients had to be aged between 18 and 75 years and have probable or definite MND based on El Escorial criteria, with a disease duration of less than 5 years and a vital capacity greater than 60% before study entry. Patients were prescribed riluzole 50 mg twice daily. Safety data were collected through documentation of adverse events by clinical history in combination with regular laboratory screening. Full blood count, haematocrit, differential white cell counts and serum liver transaminase levels were obtained monthly for 3 months, and then at each 3-monthly visit for 1 year. In total, 25 patients with MND (17 male, 8 female; age range 40-74 years; mean age 59 years) were commenced on riluzole. Of these, 28% had definite MND and the remaining 72% were diagnosed as probable MND, with the majority (84%) having limb-onset MND. At 12 months, 68% of patients continued on riluzole, 16% had died from their disease and 16% ceased riluzole because of side-effects or other reasons, largely disenchantment owing to a perceived lack of efficacy. Haematological and biochemical assays showed no significant alteration during the initial 12-month period. Long-term survival data for patients in the present series suggest a greater benefit for patients who commenced riluzole early in the course of their illness. In conclusion, riluzole was generally tolerated well by Australian patients with MND. Of the few patients who experienced side-effects attributed to riluzole, all were reversible. Issues related to patient perceptions of efficacy highlight the need for patients and treating physicians to maintain realistic expectations of riluzole therapy." @default.
• W2033976809 created "2016-06-24" @default.
• W2033976809 creator A5048648105 @default.
• W2033976809 creator A5050376199 @default.
• W2033976809 creator A5060424866 @default.
• W2033976809 creator A5089232512 @default.
• W2033976809 date "2006-01-01" @default.
• W2033976809 modified "2023-10-13" @default.
• W2033976809 title "Riluzole therapy for motor neurone disease: An early Australian experience (1996–2002)" @default.
• W2033976809 cites W1215506979 @default.
• W2033976809 cites W1747517521 @default.
• W2033976809 cites W1964177214 @default.
• W2033976809 cites W1992573335 @default.
• W2033976809 cites W1993024959 @default.
• W2033976809 cites W2043111031 @default.
• W2033976809 cites W2065845618 @default.
• W2033976809 cites W2068201081 @default.
• W2033976809 cites W2085165928 @default.
• W2033976809 cites W2089214636 @default.
• W2033976809 cites W2096386031 @default.
• W2033976809 cites W2107768418 @default.
• W2033976809 cites W2123676540 @default.
• W2033976809 cites W2140860447 @default.
• W2033976809 cites W2143351671 @default.
• W2033976809 cites W2147991514 @default.
• W2033976809 cites W2168841100 @default.
• W2033976809 cites W2314689571 @default.
• W2033976809 cites W2442050277 @default.
• W2033976809 doi "https://doi.org/10.1016/j.jocn.2004.04.011" @default.
• W2033976809 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16410201" @default.
• W2033976809 hasPublicationYear "2006" @default.
• W2033976809 type Work @default.
• W2033976809 sameAs 2033976809 @default.
• W2033976809 citedByCount "32" @default.
• W2033976809 countsByYear W20339768092012 @default.
• W2033976809 countsByYear W20339768092013 @default.
• W2033976809 countsByYear W20339768092014 @default.
• W2033976809 countsByYear W20339768092015 @default.
• W2033976809 countsByYear W20339768092016 @default.
• W2033976809 countsByYear W20339768092017 @default.
• W2033976809 countsByYear W20339768092018 @default.
• W2033976809 countsByYear W20339768092019 @default.
• W2033976809 countsByYear W20339768092021 @default.
• W2033976809 countsByYear W20339768092022 @default.
• W2033976809 countsByYear W20339768092023 @default.
• W2033976809 crossrefType "journal-article" @default.
• W2033976809 hasAuthorship W2033976809A5048648105 @default.
• W2033976809 hasAuthorship W2033976809A5050376199 @default.
• W2033976809 hasAuthorship W2033976809A5060424866 @default.
• W2033976809 hasAuthorship W2033976809A5089232512 @default.
• W2033976809 hasConcept C126322002 @default.
• W2033976809 hasConcept C1862650 @default.
• W2033976809 hasConcept C187212893 @default.
• W2033976809 hasConcept C197934379 @default.
• W2033976809 hasConcept C2778466831 @default.
• W2033976809 hasConcept C2779134260 @default.
• W2033976809 hasConcept C2779319286 @default.
• W2033976809 hasConcept C2780596555 @default.
• W2033976809 hasConcept C535046627 @default.
• W2033976809 hasConcept C71924100 @default.
• W2033976809 hasConceptScore W2033976809C126322002 @default.
• W2033976809 hasConceptScore W2033976809C1862650 @default.
• W2033976809 hasConceptScore W2033976809C187212893 @default.
• W2033976809 hasConceptScore W2033976809C197934379 @default.
• W2033976809 hasConceptScore W2033976809C2778466831 @default.
• W2033976809 hasConceptScore W2033976809C2779134260 @default.
• W2033976809 hasConceptScore W2033976809C2779319286 @default.
• W2033976809 hasConceptScore W2033976809C2780596555 @default.
• W2033976809 hasConceptScore W2033976809C535046627 @default.
• W2033976809 hasConceptScore W2033976809C71924100 @default.
• W2033976809 hasIssue "1" @default.
• W2033976809 hasLocation W20339768091 @default.
• W2033976809 hasLocation W20339768092 @default.
• W2033976809 hasOpenAccess W2033976809 @default.
• W2033976809 hasPrimaryLocation W20339768091 @default.
• W2033976809 hasRelatedWork W2076153179 @default.
• W2033976809 hasRelatedWork W2113542630 @default.
• W2033976809 hasRelatedWork W2166455544 @default.
• W2033976809 hasRelatedWork W2314689571 @default.
• W2033976809 hasRelatedWork W2340610284 @default.
• W2033976809 hasRelatedWork W2772668409 @default.
• W2033976809 hasRelatedWork W4205595123 @default.
• W2033976809 hasRelatedWork W4213128270 @default.
• W2033976809 hasRelatedWork W4232175805 @default.
• W2033976809 hasRelatedWork W4383343129 @default.
• W2033976809 hasVolume "13" @default.
• W2033976809 isParatext "false" @default.
• W2033976809 isRetracted "false" @default.
• W2033976809 magId "2033976809" @default.
• W2033976809 workType "article" @default.